A proposal to prevent severe neonatal hyperbilirubinemia and kernicterus

Journal of Perinatology

Volumn 29, Issue , 2009, Pages S61-S67

  Bhutani, V K ^a   Johnson, L ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pennsylvania Center for Kernicterus   (United States)

Author keywords

Bilirubin; Bilirubin induced neurologic dysfunction; Hyperbilirubinemia; Kernicterus; Newborn jaundice; Well babies

Indexed keywords

BILIRUBIN;

BILIRUBIN BLOOD LEVEL; BREAST FEEDING; CLINICAL PRACTICE; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; EXCHANGE BLOOD TRANSFUSION; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; KERNICTERUS; NEUROLOGIC DISEASE; NEUROTOXICITY; NEWBORN; NEWBORN CARE; NEWBORN JAUNDICE; OUTCOMES RESEARCH; PATIENT SAFETY; PHOTOTHERAPY; PRACTICE GUIDELINE; PUBLIC HEALTH; REVIEW;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); HEALTH POLICY; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; KERNICTERUS; NEONATAL SCREENING; PRACTICE GUIDELINES AS TOPIC; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; RISK MANAGEMENT; UNITED STATES;

EID: 59549107547     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2008.213     Document Type: Review

References (20)

1. Johnson LH, Brown AK, Bhutani VK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 2002; 140: 396–403.
2. American Academy of Pediatrics. Subcommittee on Hyperbilirubinemia, Maisels MJ, Baltz RD, Bhutani VK, Newman TB, Palmer H, Rosenfeld W et al. Clinical Practice Guideline: Management of Hyperbilirubinemia in the Newborn Infant X35 Weeks of Gestation. Pediatrics 2004; 114: 297–316. http://www.aappolicy.aappublications.org/gi/content/full/pediatrics;114/1/297.
3. Bhutani VK, Johnson LH, Maisels MJ, Newman TB, Phibbs C, Stark AR et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol 2004; 24(10): 650–662.
4. Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics 1993; 92(5): 651–657.
5. Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 2000; 154: 1140–1147.
6. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr 2000; 89: 1213.
7. Sheridan SE. Prevention of kernicterus and the parents of infants and children with kernicterus (PICK) organization. J Perinatol 2005; 25(4): 227–228.
8. Kaplan M, Bromiker R, Schimmel MS, Algur N, Hammerman C. Evaluation of discharge management in the prediction of hyperbilirubinemia: the Jerusalem experience. J Pediatr 2007; 150: 412–417.
9. Manning DJ, Maxwell MJ, Todd PJ, Platt MJ. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the United Kingdom and Ireland. Arch Dis Child Fetal Neonatal Ed. Online publication. 0.1136/adc.2006.105361. http://fn.bmj.com/cgi/rapidpdf/adc.2006.105361v1.
10. Newman TB, Liljestrand P, Jeremy RJ, Ferriero DM, Wu YW, Hudes ES, et al., Jaundice and Infant Feeding Study Team. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 2006; 354(18): 1889–1900.
11. Bhutani VK, Johnson LH, Schwoebel A, Gennaro S. A systems approach for neonatal hyperbilirubinemia in term and near-term newborns. J Obstet Gynecol Neonatal Nurs 2006; 35: 444–455.
12. Facchini FP, Mezzacappa MA, Rosa IR, Mezzacappa Filho F, Aranha-Netto A, Marba ST. Follow-up of neonatal jaundice in term and late premature newborns. J Pediatr (Rio J) 2007; 83(4): 313–322.
13. Ip S, Chung M, Kulig J, O’Brien R, Sege R, Glicken S, et al. Subcommittee on Hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004; 114: e130–e153.
14. Lannon C, Stark AR. Closing the gap between guidelines and practice: ensuring safe and healthy beginnings. Pediatrics 2004; 114: 494–496.
15. Center for Disease Control and Prevention. Kernicterus/Newborn Jaundice. http://www.cdc.gov/ncbddd/dd/kernichome.htm.
16. Lazarus C, Avchen RN. Neonatal hyperbilirubinemia management: a model for change. J Perinatol 2009; 29(Suppl 1): S58–S60.
17. Eggert LD, Wiedmeier SE, Wilson J, Christensen RD. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics 2006; 117: e855–e862.
18. Ebbesen F, Andersson C, Verder H, Grytter C, Pedersen-Bjergaard L, Petersen JR et al. Extreme hyperbilirubinaemia in term and near-term infants in Denmark. Acta Paediatr 2005; 94: 59–64.
19. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 2006; 175: 587–590.
20. Lo SF, Doumas BT, Ashwood ER. College of American Pathologists. Bilirubin proficiency testing using specimens containing unconjugated bilirubin and human serum: results of a College of American Pathologists study. Arch Pathol Lab Med 2004; 128(11): 1219–1223.